Secondary plant metabolites as potent drug candidates against antimicrobial-resistant pathogens

SN Appl Sci. 2022;4(8):209. doi: 10.1007/s42452-022-05084-y. Epub 2022 Jul 8.

Abstract

Antibiotic resistance is a major public health threat of the twenty-first century and represents an important risk to the global economy. Healthcare-associated infections mainly caused by drug-resistant bacteria are wreaking havoc in patient care worldwide. The spread of such pathogens limits the utility of available drugs and complicates the treatment of bacterial diseases. As a result, there is an urgent need for new drugs with mechanisms of action capable of curbing resistance. Plants synthesize and utilize various metabolic compounds to deter pathogens and predators. Utilizing these plant-based metabolites is a promising option in identifying novel bioactive compounds that could be harnessed to develop new potent antimicrobial drugs to treat multidrug-resistant pathogens. The purpose of this review is to highlight medicinal plants as important sources of novel antimicrobial agents that could be developed to help combat antimicrobial resistance.

Keywords: Anti-infective agents; Antibacterial drug screening; Antimicrobial resistance; Multidrug-resistant pathogens; Plant metabolites; Plant secondary metabolites; Plant-based medical compounds.

Publication types

  • Review